A phase II/III randomized, multicenter trial of prednisone/sirolimus <i>versus</i> prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-<i>versus</i>-host disease: BMT CTN 0801Paul A. Carpenter, Mukta Arora, Brent R. Logan et al.|Haematologica|2018Cited by 55
Transplant Physicians’ Attitudes on Candidacy for Allogeneic Hematopoietic Cell Transplantation (HCT) in Older Patients: The Need for a Standardized Geriatric Assessment (GA) ToolAsmita Mishra, Andrew Artz, Parastoo B. Dahi et al.|Transplantation and Cellular Therapy|2020Cited by 6
Prednisone (PDN)/Sirolimus (SRL) Compared to PDN/SRL/Calcineurin Inhibitor (CNI) as Treatment for Chronic Graft-Versus-Host-Disease (cGVHD): A Randomized Phase II Study from the Blood and Marrow Transplant Clinical Trials NetworkPaul A. Carpenter, Mukta Arora, Brent R. Logan et al.|Transplantation and Cellular Therapy|2016Cited by 5
Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous TransplantationAbraham S. Kanate, Robert Lowsky, Bradley Efron et al.|Transplantation and Cellular Therapy|2013Cited by 0